Stock Chart
Stock Chart
-
Previous Close2.18
-
Open2.14
-
Bid0
-
Ask0
-
Day's Range2.0287 - 2.16
-
52 week Range0.6 - 2.62
-
Volume118297
-
Avg. Volume222565
-
Market Cap77537646
-
Beta (5Y Monthly)2.14
-
PE Ratio (TTM)
-
EPS (TTM)0
-
Earnings Date2.14
-
Forward Dividend & Yield2.14
-
Ex-Dividend Date119732
-
1y Target Est2.14
KEEP ME INFORMED ON ANCN UPDATES
ANCN Performance
-
5 Day7.3891625615764%1 Month-8.4033613445378%3 Month89.565217391304%YTD26.011560693642%1 Year37.974683544304%
ANCN on Twitter
-
Tue, Jan 19, 10:14 am
-
Sat, Jan 16, 11:15 am
-
Fri, Jan 15, 5:25 pm
-
Fri, Jan 15, 3:42 pm
-
Fri, Jan 15, 3:29 pm
-
Fri, Jan 15, 3:29 pm
-
Fri, Jan 15, 3:18 pm
-
Fri, Jan 15, 9:46 am
-
Fri, Jan 15, 9:45 am
-
Fri, Jan 15, 9:45 am
-
Fri, Jan 15, 1:03 am
-
Fri, Jan 15, 12:51 am
-
Thu, Jan 14, 5:27 pm
ANCN on iHub
-
Tue, Dec 15, 4:06 pm
-
Tue, Dec 15, 11:32 am
-
Tue, Dec 15, 10:38 am
-
Thu, Nov 19, 12:02 pm
-
Tue, Nov 10, 12:22 pm
-
Tue, Nov 10, 6:04 am
-
Mon, Nov 9, 10:55 am
-
Fri, Nov 6, 7:21 pm
-
Thu, Nov 5, 4:05 pm
-
Wed, Oct 21, 12:10 pm
-
Tue, Oct 20, 8:11 pm
-
Tue, Oct 20, 6:39 pm
-
Tue, Oct 20, 5:20 pm
-
Tue, Oct 20, 4:02 pm
-
Tue, Oct 20, 2:02 pm
-
Tue, Oct 20, 12:25 pm
-
Tue, Jul 21, 10:54 pm
-
Sat, Jul 18, 9:08 am
-
Sat, Jul 18, 8:59 am
-
Wed, Jul 15, 12:12 pm
-
Tue, Jul 14, 10:14 am
-
Wed, Jun 10, 7:05 am
ANCN News
-
Sat, Jan 16, 11:12 am
ANCHIANO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. - ANCN
-
Wed, Jan 13, 6:25 pm
SHAREHOLDER ALERT: WeissLaw LLP Reminds CHNG, CPAH, CATM, and ANCN Shareholders About Its Ongoing Investigations
-
Wed, Jan 13, 4:13 pm
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Anchiano Therapeutics Ltd. - ANCN
-
Wed, Jan 6, 4:34 pm
SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, WORK, and GNBF Shareholders About Its Ongoing Investigations
-
Wed, Dec 30, 8:49 pm
SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, TLRY, and GNBF Shareholders About Its Ongoing Investigations
-
Thu, Dec 24, 11:49 pm
Lifshitz Law Firm, P.C. Announces Investigation of ANCN, BEAT, HMSY, SNCA, SPWH, TCP, TRP, TLRY, and APHA
-
Tue, Dec 22, 7:11 pm
SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, BRPA, and TPGY Shareholders About Its Ongoing Investigations
-
Mon, Dec 21, 11:00 am
Moore Kuehn Encourages BEAT, AJRD, ANCN, and RNET Investors to Contact Law Firm
-
Thu, Dec 17, 10:37 am
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Anchiano Therapeutics Ltd. Merger
-
Wed, Dec 16, 7:15 am
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
-
Tue, Dec 15, 5:16 pm
SHAREHOLDER ALERT: WeissLaw LLP Investigates Anchiano Therapeutics Ltd.
-
Tue, Dec 15, 9:00 am
Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement
-
Thu, Oct 8, 12:00 pm
All You Need to Know About Anchiano Therapeutics Ltd. Sponsored ADR (ANCN) Rating Upgrade to Buy
-
Tue, May 26, 8:00 am
Anchiano Appoints Stan Polovets as Chairman of the Board
-
Mon, May 11, 4:01 pm
Anchiano Therapeutics Reports First Quarter 2020 Financial Results
-
Tue, May 5, 6:13 pm
Anchiano Appoints Steve DiPalma as Chief Financial Officer
-
Fri, Apr 17, 4:01 pm
Anchiano to Hold Virtual Annual Meeting of Shareholders
-
Wed, Mar 18, 8:00 am
Anchiano Therapeutics Reports Year-End 2019 Financial Results
Copyright © 2012. 007 Stock Chat, LLC